AKAN
Price
$1.33
Change
-$0.29 (-17.90%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
235.96K
Intraday BUY SELL Signals
LIEN
Price
$10.85
Change
+$0.06 (+0.56%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
246.23M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKAN vs LIEN

Header iconAKAN vs LIEN Comparison
Open Charts AKAN vs LIENBanner chart's image
Akanda
Price$1.33
Change-$0.29 (-17.90%)
Volume$3.18K
Capitalization235.96K
Chicago Atlantic BDC
Price$10.85
Change+$0.06 (+0.56%)
Volume$858
Capitalization246.23M
AKAN vs LIEN Comparison Chart in %
AKAN
Daily Signal:
Gain/Loss:
LIEN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKAN vs. LIEN commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and LIEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (AKAN: $1.62 vs. LIEN: $10.79)
Brand notoriety: AKAN and LIEN are both not notable
AKAN represents the Pharmaceuticals: Generic, while LIEN is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: AKAN: 48% vs. LIEN: 100%
Market capitalization -- AKAN: $235.96K vs. LIEN: $246.23M
AKAN [@Pharmaceuticals: Generic] is valued at $235.96K. LIEN’s [@Investment Managers] market capitalization is $246.23M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $169.4B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.59B. The average market capitalization across the [@Investment Managers] industry is $7.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileLIEN’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • LIEN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIEN is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 4 TA indicator(s) are bullish while LIEN’s TA Score has 4 bullish TA indicator(s).

  • AKAN’s TA Score: 4 bullish, 3 bearish.
  • LIEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AKAN is a better buy in the short-term than LIEN.

Price Growth

AKAN (@Pharmaceuticals: Generic) experienced а -41.28% price change this week, while LIEN (@Investment Managers) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.08%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +19.08%.

The average weekly price growth across all stocks in the @Investment Managers industry was +0.83%. For the same industry, the average monthly price growth was +4.66%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

LIEN is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (+0.83% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIEN($246M) has a higher market cap than AKAN($236K). LIEN has higher P/E ratio than AKAN: LIEN (6.13) vs AKAN (0.01). LIEN YTD gains are higher at: 4.453 vs. AKAN (-29.149). AKAN has more cash in the bank: 2.52M vs. LIEN (5.4K). AKAN has less debt than LIEN: AKAN (391K) vs LIEN (11M). LIEN has higher revenues than AKAN: LIEN (39.9M) vs AKAN (837K).
AKANLIENAKAN / LIEN
Capitalization236K246M0%
EBITDA-2.22MN/A-
Gain YTD-29.1494.453-655%
P/E Ratio0.016.130%
Revenue837K39.9M2%
Total Cash2.52M5.4K46,741%
Total Debt391K11M4%
TECHNICAL ANALYSIS
Technical Analysis
AKANLIEN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
54%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 16 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signal:
Gain/Loss:
LIEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWGL5.060.09
+1.86%
Crimson Wine Group Ltd.
SDVKF34.50N/A
N/A
Sandvik AB
SNCPF54.30N/A
N/A
Sun Corp.
YORUF25.87N/A
N/A
Yokohama Rubber Co., Ltd.
AVOA1175.00N/A
N/A
Avoca LLC

AKAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKAN has been loosely correlated with CRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AKAN jumps, then CRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
-17.77%
CRON - AKAN
43%
Loosely correlated
-2.59%
TLRY - AKAN
36%
Loosely correlated
+5.43%
OGI - AKAN
35%
Loosely correlated
-4.73%
ACB - AKAN
33%
Poorly correlated
+0.47%
CGC - AKAN
30%
Poorly correlated
-2.40%
More

LIEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIEN has been loosely correlated with TXMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LIEN jumps, then TXMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
+3.06%
TXMD - LIEN
36%
Loosely correlated
+1.90%
AVDL - LIEN
24%
Poorly correlated
+0.09%
SHPH - LIEN
21%
Poorly correlated
+6.29%
OXLCP - LIEN
11%
Poorly correlated
+0.11%
AKAN - LIEN
9%
Poorly correlated
-17.77%
More